L''Oreal: 1 director

A director at L'Oreal sold 6,600 shares at 373.921EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

IBERIAN DAILY 11 DECEMBER (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: CAF, INDRA, NATURGY. The FED cut rates, as expected With the Ibex remaining near highs, the lack of definition continued for European stock markets, awaiting the Fed’s decision. In the STOXX 600, Basic Resources and Banks led the gains whereas Autos and Construction (after an equity research firm cut Vinci’s recommendation) were the worst performers. On the macro side, in the US, as expected, the Fed cut interest rates by 25bps to 3.5%-3.75% (with 1 member in favour of cutting -5...

INFORME DIARIO 11 DICIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, INDRA, NATURGY. EUROPA: MUNICH RE. La FED cumple con el recorte de tipos Con el Ibex manteniéndose cerca de sus máximos las bolsas europeas continuaron una jornada más con cierta indefinición a la espera de catalizadores. En el STOXX 600, los mejores sectores fueron R. Básicos y Bancos mientras que Autos y Construcción (afectado por la rebaja de recomendación a Vinci por parte de una casa de análisis) fueron los que más cayeron. Por el lado m...

IBERIAN DAILY 10 DECEMBER (ANÁLISIS BANCO SABADELL)

NEWS SUMMARY: CHANGES IBEX 35, GRUPO CATALANA OCCIDENTE, INDRA, SACYR. Stock markets on stand by European stock markets saw a second session of stability, awaiting the Fed’s decision to be made public tomorrow. In the STOXX 600, Insurance and Household led the gains whereas Pharma and Constructions were the worst performers. On the macro side, the ECB will propose merging the systemic risk buffer and the countercyclical capital buffer instead of reducing the capital buffers demanded of banks. I...

INFORME DIARIO 10 DICIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAMBIOS IBEX, GRUPO CATALANA OCCIDENTE, INDRA, SACYR. Bolsas en stand by Segunda sesión de estabilidad en las bolsas europeas, a la espera de la decisión de la Fed de mañana. En el STOXX 600, los mejores sectores fueron Seguros y Hogar mientras que Farma y Construcción quedaron con las mayores correcciones. Por el lado macro, desde el BCE se propondrá fusionar el colchón de riesgo sistémico y el colchón de capital anticíclico en lugar de reducir los...

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 12/08/2025

ODDO BHF SECURITIES LARGE CAPS MORNING NEWS 08/12/2025

L'Oreal : CMD feedback: optimism on the potential of the US. Global ma...

L'Oréal : Feedback CMD : optimisme sur le potentiel des USA. Marché mo...

INFORME DIARIO 02 DICIEMBRE (ANÁLISIS BANCO SABADELL)

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: INDITEX, REPSOL, SANTANDER. EUROPA: BAYER, L’ORÉAL. Diciembre arranca con caídas Las bolsas a ambos lados del Atlántico comenzaron la semana con descensos, en una jornada marcada por la cautela. El Ibex 35 interrumpió su racha de cinco sesiones consecutivas al alza mientras que el riesgo geopolítico sigue en aumento después de que D. Trump ordenara cerrar el espacio aéreo de Venezuela. En el STOXX 600, Hogar y R. Básicos fueron los que más subieron...

CAF: 9M’25 RESULTS AND CHANGE OF T.P. TO UNDER REVISION (ANÁLISIS BANC...

3Q'25 vs. 3Q'24 Results Sales: € 986.0 M (+17.7% vs. +10.0% BS(e) and +12.6% consensus); EBIT: € 47.0 M (+34.3% vs. +37.7% BS(e) and +42.9% consensus); Net Profit: € 27.0 M (+200.0% vs. +173.3% BS(e) and +211.1% consensus); 9M'25 vs. 9M'24 Results Sales: € 3.165 Bn (+8.5% vs. +6.3% BS(e) and +7.0% consensus); EBIT: € 161.0 M (+17.5% vs. +18.4% BS(e) and +19.7% consensus); Net Profit: € 100.0 M (+63.9% vs. +60.0% BS(e) and +65.6% consensus);

SACYR: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)

3Q'25 vs. 3Q'24 Results Sales: € 1.175 Bn (2.8% vs. 3.1% BS(e) and 1.3% consensus); EBITDA: € 371 M (27.7% vs. 23.0% BS(e) and 20.1% consensus); EBIT: € 273 M (1.2% vs. 15.2% BS(e) and 20.2% consensus); Net Profit: € 31 M (41.5% vs. 35.1% BS(e) and 70.7% consensus). 9M'25 vs. 9M'24 Results Sales: € 3.412 Bn (4.6% vs. 4.7% BS(e) and 4.0% consensus); EBITDA: € 1.018 Bn (7.4% vs. 6.0% BS(e) and 5.1% consensus); EBIT: € 737 M (-15.2% vs. -10.9% BS(e) and -9.3% consensus); Net Profit: € 62 M (-16.2%...

SACYR: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 3T'25 vs 3T'24: Ventas: 1.175 M euros (2,8% vs 3,1% BS(e) y 1,3% consenso); EBITDA: 371 M euros (27,7% vs 23,0% BS(e) y 20,1% consenso); EBIT: 273 M euros (1,2% vs 15,2% BS(e) y 20,2% consenso); BDI: 31 M euros (41,5% vs 35,1% BS(e) y 70,7% consenso). Rdos. 9M'25 vs 9M'24: Ventas: 3.412 M euros (4,6% vs 4,7% BS(e) y 4,0% consenso); EBITDA: 1.018 M euros (7,4% vs 6,0% BS(e) y 5,1% consenso); EBIT: 737 M euros (-15,2% vs -10,9% BS(e) y -9,3% consenso); BDI: 62 M euros (-16,2% vs -18,2% BS...

IBERIAN DAILY 07 NOVEMBER + 3Q'25 RESULTS. HIGHLIGHTS AND REST OF PREV...

NEWS SUMMARY: ACS, AMADEUS, CELLNEX, IAG, SACYR. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’25 results to be released over the coming days in Spain. Doubts persist With the results campaign entering the final stretch, the main European indices closed with losses, with the IBEX standing out as the best performer, remaining at around 16,100. In the STOXX 600, Basic Mate...